CRAD001C2X01B

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.


Carl and Dorothy Bennett Cancer Center at Stamford Hospital
34 Shelburne Road
Stamford, CT 06902

Clinical Research Alliance SC
Lake Success, NY 11042
855-737-2873

Central Indiana Cancer Centers SC
Indianapolis, IN 46227
317-678-2739

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
660 South Euclid Avenue
St. Louis, MO 63110
314-362-8516

Hematology Oncology Services of Arkansas
9101 Kanis Road
Suite 200
Little Rock, AR 72205

Crescent City Research Consortium
Metairie, LA 70006
504-883-2968

Rocky Mountain Cancer Centers - Greenwood Village
Greenwood Village, CO 80111
303-418-7600

Utah Cancer Specialists Utah Cancer (2)
Salt Lake City, UT 84106
801-281-6863

Knight Cancer Institute at Oregon Health and Science University
3181 Southwest Sam Jackson Park Road
Portland, OR 97239
503-494-1091

Novartis Investigative Site
Seoul 120-752

Novartis Investigative Site
Seoul 110 744

Novartis Investigative Site
Arezzo 52100

Novartis Investigative Site
Milano 20133